This whitepaper provides an overview of developing a comprehensive contamination control strategy (CCS), taking into consideration the various aspects of pharmaceutical manufacturing.
Learn more about the authors below.
Whitepaper
WHITEPAPER
Developing a Contamination Control Strategy
September 15, 2023 | By: Susan Schniepp and Martell Winters
Martell Winters
RM/SM (NRCM), CISS-RAD
Scientific Competency Expert
Martell Winters is a specialist microbiologist (NRCM) and a radiation specialist (AAMI). He has been at Nelson Labs for 24 years and spent his earlier years working in the Radiation Sterilization group, responsible for bioburden testing and radiation validation studies. His specialties include microbiological process validation and radiation sterilization of medical devices, allograft tissue, and pharmaceutical products.
Susan Schniepp
Pharmaceuticals Quality Assurance Expert
Susan has over 40 years of quality-assurance experience in the pharmaceutical industry. She has earned several awards from the Parenteral Drug Association (PDA), including Distinguished Author Award, Distinguished Service Award, and Gordon Personeus Award. Serving as a volunteer in a number of capacities, she has served on the PDA Board of Directors from 2011 to...
Complete the information in the form below to access the whitepaper.
